JPGN Journal Club January 2023: Oral Immunotherapy and Eosinophilic Esophagitis, Plus Hypnotherapy in Functional GI Disorders

Dr. Alex Knisely is talking to Prof. Andreas Jenke — based in Kassel, Germany; but that’s less important today than is his position on the ESPGHAN Education Committee. Enough touchy-feely in these podcasts it’s Journal Club today, where two articles of particular interest and significance from the January, 2023, number of JPGN are discussed.  Neither article, however, lays down the law: THIS IS WHAT TO DO. One, an immense retrospective study of oral immunotherapy and the chance that it might predispose to eosinophilic oesophagitis, is most of note for making clear what must now be addressed in prospective work. The other attempts to position ESPGHAN in relation to hypnotherapy for functional hollow-viscus disease . . . so little has been done, so little is known, how can the discipline move forward in assessing what this approach offers? Well, pull out your copy of the journal, and after you’ve formed opinions on the two contributions, listen to how Andreas holds them up as of value, and to how Alex tries, gently, to say, “But, wait . . . “.